Australian scientists resolve a key question in ovarian cancer care

[News]

Australian scientists have revealed a better way to identify which patients should respond to powerful ovarian cancer drugs called PARP inhibitors (PARPi), resolving an important question in ovarian cancer care about why some patients respond to these drugs, while others do not.

More... (https://www.news-medical.net/news/20180928/Australian-scientists-resolve-a-key-question-in-ovarian-cancer-care.aspx)